Company / Current Liabilities
Cytosorbents Corp Current Liabilities History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$6.9M
FY2018
5-year range
$3.0M / $7.8M
FY2014-FY2018
Trend
-11.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 8 years, ranging from $2M in FY2011 to $8M in FY2017.
Based on SEC 10-K filings.
$7M in FY2018 with a 5-year CAGR of +17.7%.
Increased from $6M to $7M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +31.5%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +17.7%, indicating consistent growth.
- In FY2018, current liabilities decreased 11.9% year-over-year.
- Peak current liabilities was recorded in FY2017.
- Lowest current liabilities in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $6.9M | -11.9% |
| FY2017 | $7.8M | +28.9% |
| FY2016 | $6.1M | +100.1% |
| FY2015 | $3.0M | -32.4% |
| FY2014 | $4.5M | +47.0% |
| FY2013 | $3.1M | +47.6% |
| FY2012 | $2.1M | +35.9% |
| FY2011 | $1.5M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026